241 related articles for article (PubMed ID: 31320321)
1. Distinct clinical and biological implications of
Aly M; Ramdzan ZM; Nagata Y; Balasubramanian SK; Hosono N; Makishima H; Visconte V; Kuzmanovic T; Adema V; Nazha A; Przychodzen BP; Kerr CM; Sekeres MA; Abazeed ME; Nepveu A; Maciejewski JP
Blood Adv; 2019 Jul; 3(14):2164-2178. PubMed ID: 31320321
[TBL] [Abstract][Full Text] [Related]
2. Clinically Significant CUX1 Mutations Are Frequently Subclonal and Common in Myeloid Disorders With a High Number of Co-mutated Genes and Dysplastic Features.
Dermawan JK; Wensel C; Visconte V; Maciejewski JP; Cook JR; Bosler DS
Am J Clin Pathol; 2022 Apr; 157(4):586-594. PubMed ID: 34661647
[TBL] [Abstract][Full Text] [Related]
3. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.
McNerney ME; Brown CD; Wang X; Bartom ET; Karmakar S; Bandlamudi C; Yu S; Ko J; Sandall BP; Stricker T; Anastasi J; Grossman RL; Cunningham JM; Le Beau MM; White KP
Blood; 2013 Feb; 121(6):975-83. PubMed ID: 23212519
[TBL] [Abstract][Full Text] [Related]
4. The significance of CUX1 and chromosome 7 in myeloid malignancies.
Jotte MRM; McNerney ME
Curr Opin Hematol; 2022 Mar; 29(2):92-102. PubMed ID: 35084368
[TBL] [Abstract][Full Text] [Related]
5. Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.
An N; Khan S; Imgruet MK; Gurbuxani SK; Konecki SN; Burgess MR; McNerney ME
Blood; 2018 Jun; 131(24):2682-2697. PubMed ID: 29592892
[TBL] [Abstract][Full Text] [Related]
6. Recurrent genetic defects on chromosome 5q in myeloid neoplasms.
Hosono N; Makishima H; Mahfouz R; Przychodzen B; Yoshida K; Jerez A; LaFramboise T; Polprasert C; Clemente MJ; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Sanada M; Cui E; Verma AK; McDevitt MA; List AF; Saunthararajah Y; Sekeres MA; Boultwood J; Ogawa S; Maciejewski JP
Oncotarget; 2017 Jan; 8(4):6483-6495. PubMed ID: 28031539
[TBL] [Abstract][Full Text] [Related]
7. HHEX promotes myeloid transformation in cooperation with mutant ASXL1.
Takeda R; Asada S; Park SJ; Yokoyama A; Becker HJ; Kanai A; Visconte V; Hershberger C; Hayashi Y; Yonezawa T; Tamura M; Fukushima T; Tanaka Y; Fukuyama T; Matsumoto A; Yamasaki S; Nakai K; Yamazaki S; Inaba T; Shibata T; Inoue D; Honda H; Goyama S; Maciejewski JP; Kitamura T
Blood; 2020 Oct; 136(14):1670-1684. PubMed ID: 32492700
[TBL] [Abstract][Full Text] [Related]
8. Consequences of mutant TET2 on clonality and subclonal hierarchy.
Hirsch CM; Nazha A; Kneen K; Abazeed ME; Meggendorfer M; Przychodzen BP; Nadarajah N; Adema V; Nagata Y; Goyal A; Awada H; Asad MF; Visconte V; Guan Y; Sekeres MA; Olinski R; Jha BK; LaFramboise T; Radivoyevitch T; Haferlach T; Maciejewski JP
Leukemia; 2018 Aug; 32(8):1751-1761. PubMed ID: 29795413
[TBL] [Abstract][Full Text] [Related]
9. Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms.
Imgruet MK; Lutze J; An N; Hu B; Khan S; Kurkewich J; Martinez TC; Wolfgeher D; Gurbuxani SK; Kron SJ; McNerney ME
Blood; 2021 Sep; 138(9):790-805. PubMed ID: 34473231
[TBL] [Abstract][Full Text] [Related]
10. Novel CUX1 missense mutation in association with 7q- at leukemic transformation of MPN.
Thoennissen NH; Lasho T; Thoennissen GB; Ogawa S; Tefferi A; Koeffler HP
Am J Hematol; 2011 Aug; 86(8):703-5. PubMed ID: 21674579
[No Abstract] [Full Text] [Related]
11. [Genetic defects of chromosome 5q and 7q in myeloid neoplasms].
Hosono N
Rinsho Ketsueki; 2019; 60(7):800-809. PubMed ID: 31391370
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells.
An N; Khan S; Imgruet MK; Jueng L; Gurbuxani S; McNerney ME
Oncogene; 2023 Mar; 42(12):881-893. PubMed ID: 36725889
[TBL] [Abstract][Full Text] [Related]
13. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.
Bacher U; Weissmann S; Kohlmann A; Schindela S; Alpermann T; Schnittger S; Kern W; Haferlach T; Haferlach C
Br J Haematol; 2012 Jan; 156(1):67-75. PubMed ID: 22017486
[TBL] [Abstract][Full Text] [Related]
14. Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia.
Supper E; Rudat S; Iyer V; Droop A; Wong K; Spinella JF; Thomas P; Sauvageau G; Adams DJ; Wong CC
Nat Commun; 2021 Apr; 12(1):2482. PubMed ID: 33931647
[TBL] [Abstract][Full Text] [Related]
15. Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.
Wu X; Feng F; Yang C; Zhang M; Cheng Y; Zhao Y; Wang Y; Che F; Zhang J; Heng X
J Mol Neurosci; 2019 Dec; 69(4):527-537. PubMed ID: 31377983
[TBL] [Abstract][Full Text] [Related]
16. Inactivating CUX1 mutations promote tumorigenesis.
Wong CC; Martincorena I; Rust AG; Rashid M; Alifrangis C; Alexandrov LB; Tiffen JC; Kober C; ; Green AR; Massie CE; Nangalia J; Lempidaki S; Döhner H; Döhner K; Bray SJ; McDermott U; Papaemmanuil E; Campbell PJ; Adams DJ
Nat Genet; 2014 Jan; 46(1):33-8. PubMed ID: 24316979
[TBL] [Abstract][Full Text] [Related]
17. SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.
Inoue D; Kitaura J; Matsui H; Hou HA; Chou WC; Nagamachi A; Kawabata KC; Togami K; Nagase R; Horikawa S; Saika M; Micol JB; Hayashi Y; Harada Y; Harada H; Inaba T; Tien HF; Abdel-Wahab O; Kitamura T
Leukemia; 2015 Apr; 29(4):847-57. PubMed ID: 25306901
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.
Jankowska AM; Szpurka H; Tiu RV; Makishima H; Afable M; Huh J; O'Keefe CL; Ganetzky R; McDevitt MA; Maciejewski JP
Blood; 2009 Jun; 113(25):6403-10. PubMed ID: 19372255
[TBL] [Abstract][Full Text] [Related]
19. RAS transformation requires CUX1-dependent repair of oxidative DNA damage.
Ramdzan ZM; Vadnais C; Pal R; Vandal G; Cadieux C; Leduy L; Davoudi S; Hulea L; Yao L; Karnezis AN; Paquet M; Dankort D; Nepveu A
PLoS Biol; 2014 Mar; 12(3):e1001807. PubMed ID: 24618719
[TBL] [Abstract][Full Text] [Related]
20. CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.
Ramdzan ZM; Nepveu A
Nat Rev Cancer; 2014 Oct; 14(10):673-82. PubMed ID: 25190083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
